Viewing Study NCT01249456


Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2026-05-23 @ 4:08 AM
Study NCT ID: NCT01249456
Status: COMPLETED
Last Update Posted: 2015-06-25
First Post: 2010-11-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Letrozole View
None Breast Cancer View
Keywords: